Director Deals - (ORIT)

James Cameron, Non Executive Director, bought 10,198 shares in the company on the 31st March 2020 at a price of 104.80p. The Director now holds...

Wed, 01/04/2020 - 09:00


Director Deals - Touchstone Exploration Inc (TXP)

Thomas Valentine, Non Executive Director, exercised 75,000 shares in the company on the 31st March 2020 at a price of 18.90p. The Director now holds...

Wed, 01/04/2020 - 09:00


Director Deals - Touchstone Exploration Inc (TXP)

Thomas Valentine, Non Executive Director, sold post-exercise 60,000 shares in the company on the 31st March 2020 at a price of 26.30p. The Director now...

Wed, 01/04/2020 - 09:00


Director Deals - 1Spatial PLC (SPA)

Claire Milverton, Chief Executive Officer, bought 59,803 shares in the company on the 1st April 2020 at a price of 20.09p. The Director now holds...

Wed, 01/04/2020 - 09:00


Director Deals - 1Spatial PLC (SPA)

Andrew Roberts, Chief Executive Officer, bought 142,857 shares in the company on the 1st April 2020 at a price of 21.00p. The Director now holds...

Wed, 01/04/2020 - 09:00


Broker Forecast - Peel Hunt issues a broker note on Informa PLC

Peel Hunt today reaffirms its hold investment rating on Informa PLC (LON:INF) and cut its price target to 740p (from 910p).

Broker Forecasts data provided...

Wed, 01/04/2020 - 09:00


Seeing Machines inks technology licencing deal with automotive group

Computer vision technology company Seeing Machines said it had forged a pre-production license deal with a 'major' automotive group that it didn't name.

Seeing Machines...

Wed, 01/04/2020 - 08:59


Central Asia Metals scraps dividend; profit falls on lower metal prices

Metal mining company Central Asia Metals scrapped plans to pay a final dividend and said it would also be reviewing its budget for 2020 in...

Wed, 01/04/2020 - 08:58


Plutus PowerGen drops plan to develop gas sites

Flexible power generation group Plutus PowerGen said it would no longer pursue a strategy of developing gas sites, having determined it couldn't generate adequate returns....

Wed, 01/04/2020 - 08:56


Futura Medical losses widen on higher research and development costs

Pharmaceutical company Futura Medical reported wider losses on higher research and development costs.

For the year ended 31 December 2019, pre-tax losses widened to £...

Wed, 01/04/2020 - 08:51


Pages